FDA MedWatch - MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz: Recall - Particles Identified

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz: Recall - Particles Identified
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz: Recall - Particles Identified

AUDIENCE: Consumer, Pharmacy, Patient, Health Professional

ISSUE: McNeil Consumer Healthcare is voluntarily recalling at the retail level three lots, approximately 200,000 bottles, of Concentrated MOTRIN Infants’ Drops Original Berry Flavor 1/2 fl oz bottles distributed in the United States (refer to Firm Press Release for full product list). 

After releasing these three lots of Concentrated MOTRIN Infants’ Drops Original Berry Flavor 1/2 fl oz into the market, tiny plastic particles (approximately 1 mm in size or about the size of a poppy seed) were identified in a different product lot during manufacturing. This lot was not released to the market. It was determined that the particles originated in a shipment from a third party supplier of ibuprofen, the active ingredient in Concentrated MOTRIN Infants’ Drops Original Berry Flavor 1/2 fl oz. Out of an abundance of caution, McNeil is voluntarily recalling the three lots released to the market made with the same batch of active ingredient.

BACKGROUND: Concentrated Infants’ MOTRIN Drops Dye-Free Berry Flavor 1 fl oz is not included in this recall. Children’s or Adult MOTRIN products are not included in this recall.  

RECOMMENDATION:  McNeil is asking retailers to remove the affected lots from store shelves, and is asking consumers to stop using and dispose of any product they may have that is included in this recall.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch Alert, including a link to the Recall Notice at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367597.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux